-
Most Popular
Biotech Stocks
Biotech is defined as using technology to change, manipulate, and harness biological processes in order to fulfill a medical need. The applications of biotech are endless and range from genetically modifying foods to creating vaccines. During the height of the coronavirus pandemic, companies like Moderna and BioNTech utilized biotech to create life-saving vaccines that were distributed across the globe.
7 Recession-Resistant Stocks to Hold Onto for Dear Life in 2024
These seven recession-resistant stocks offer stability and potential growth even in challenging economic conditions.
3 Promising Biotech Stocks for the Long-Term: August 2024
Some of the best biotech opportunities can be found in oversold obesity treatment stocks. Here are just a few.
The 3 Best Healthcare Stocks to Buy in August 2024
These are the best healthcare stocks that could bring in massive returns to the investors in the future. Do not miss out on this opportunity.
Other industries you might be interested in
Recent Biotech Stocks Articles
Royalty Pharma’s Cash Flow Growth Will Power the Stock Higher
Royalty Pharma's cash flow growth will power the stock higher. If cash flow continues at this pace, RPRX stock could rise by at least 88% over the next three years.
Biotech Stocks: This Sector Outperformed the Market in Q2
Biotech stocks are breaking out of a seven-year consolidation phase -- and fast. But this rally isn’t slowing down anytime soon.
Enough Already! Ditch Moderna Stock
Whether you bought MRNA stock for the CMV or the coronavirus catalyst, it’s clearly time to sell. With shares appearing to be topping out, cashing out today could be the best call.
Don’t Judge Pfizer by Its Vaccine Efforts
Pfizer hopes its cash and production infrastructure can quickly replace revenue lost in the spin-out of its generics and consumer businesses.
NowRX Puts Pharmacists in a Warehouse and Employees Making the Delivery
Right now NowRX is only operating in California, where it has delivered 150,000 prescriptions to 18,000 customers. But it has nationwide ambitions.
Abbvie Stock is Offering Investors an Oil Yield Without Oil’s Risk
Analysts call ABBV stock a bargain after its $63 billion purchase of Allergan, whose existing drugs and pipeline are now expected to replace revenue from Humira.
The Amazon of Pharmacy: NowRx Could Be a Big Winner
Pharmacy start-up NowRx is in the very early stages of disrupting the $400 billion legacy pharmacy market.
AbbVie Is More Than Just a Portfolio of Drugs and Acquisitions
With AbbVie's buyout of Allergan officially finalized, ABBV stock has moved significantly higher since then. However, ABBV is so much more than this headline event.
This Stock Points to the Massive China Biotech Trend
There is ridiculously big upside potential for Chinese biotech stocks in the next decade. The spread of the pandemic has only strengthened the case.
Bullish Play on Inovio as it Develops COVID-19 Vaccine
The major indexes continue to rally. Take advantage by using a bullish position on Inovio Pharmaceuticals, Inc. (NASDAQ:INO).
Technology Stock Profits Will Only Accelerate in the Post-Pandemic World
These must-own investing themes and stocks will continue to pick up steam as the world moves to a new normal after the coronavirus crisis.
Biotech Stocks: Big Buying Opportunities in 2020’s Sector of the Year
Yes, many biotech stocks are down at the moment. But that sets up an incredible chance to get some of the best at a discount.
Gilead Sciences Stock: Still Cheap but Don’t Count On a Coronavirus Rally
Gilead Sciences has scored a lot of attention with its drug that may treat coronavirus. That doesn't necessarily make GILD stock a buy yet, though.
Its Powerful Pipeline Shows Pfizer Stock Is Undervalued by 15%
Pfizer stock is gearing up for a strong 2020 as the company spins out is generics drug business, completing a merger with Mylan.
